Taylor Gentile, Pharm D, PhD
About Taylor Gentile, Pharm D, PhD
Taylor Gentile, Pharm D, PhD, is a Medical Science Liaison II at Alkermes with a background in pharmaceutical sciences and neuroscience.
Title
Taylor Gentile holds the position of Medical Science Liaison II at Alkermes. In this role, Taylor engages with healthcare professionals to provide scientific and technical support for the company's pharmaceutical products.
Previous Professional Experience
Taylor Gentile has a diverse background in both the pharmaceutical industry and academia. Previously, Taylor worked as an Associate Scientific Director at Dudnyk for one year. Taylor also served as a Pharmacist at ShopRite Supermarkets for four years. Additionally, Taylor gained experience as a Ph.D. Candidate at Temple University's Lewis Katz School of Medicine, focusing on Biomedical Graduate Studies. Early career roles include a three-year stint at Duquesne University engaging in Medicinal Chemistry Undergraduate Research and ten months as a Pharmacy Intern at Walgreens Specialty Pharmacy in Pittsburgh.
Education and Expertise
Taylor Gentile has an extensive educational background, holding a Doctor of Philosophy (Ph.D.) in Neuroscience from Temple University's Lewis Katz School of Medicine. This was attained following four years of study from 2013 to 2017. Taylor also earned a Doctor of Pharmacy (Pharm.D.) from Duquesne University, where the undergraduate degree in Pharmaceutical Sciences was completed over six years, culminating in 2013. Taylor was licensed as a pharmacist in Pennsylvania in July 2013. This combination of pharmaceutical and neuroscientific education underpins Taylor's expertise in addressing complex medical and scientific inquiries.
Research and Clinical Interests
Taylor Gentile's research and clinical interests focus on the physiologic and environmental components contributing to psychiatric disorders and their treatment modalities. Specific areas of interest include substance abuse, schizophrenia, and bipolar disorder. This research aims to enhance understanding and treatment approaches for these conditions, aiming to improve patient outcomes.